Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-25

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride from Actavis Pharma, Inc., bringing this generic product under the approved label. The appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)